Besides Tregs, other tumor-promoting immune cells, such as IL-17-producing-CD4+ T cells (T helper 17 [Th17]) (Grivennikov et al., 2012) have also been reported to be a tumor-promoting immune cell type in PDAC murine models (Hegde et al., 2020). This evidence concerns the gene IL17A and neoplasm.